Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers

Shahrokh F. Shariat, Jose A. Karam, Jochen Walz, Claus G. Roehrborn, Francesco Montorsi, Vitaly Margulis, Fred Saad, Kevin M. Slawin, Pierre I. Karakiewicz

Research output: Contribution to journalArticle

Abstract

Purpose: The preoperative blood levels of biomarkers may allow accurate identification of patients who are likely to fail radical prostatectomy as a first-line therapy for localized prostate cancer, thereby allowing more efficient delivery of neoadjuvant and adjuvant therapy. The aim of this study was to determine the added value of biomarkers relative to established predictors of biochemical recurrence, such as clinical stage, biopsy Gleason sum, and preoperative prostate-specific antigen. Experimental Design: The preoperative plasma levels of transforming growth factor-β1 (TGF-β1), interleukin-6 (IL-6), soluble IL-6 receptor (slL-6R), vascular endothelial growth factor (VEGF), vascular cell adhesion molecule-1 (VCAM-1), endoglin, urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor-1, and uPA receptor were measured with the use of commercially available enzyme immunoassays in 423 consecutive patients treated with radical prostatectomy and bilateral lymphadenectomy for clinically localized prostate cancer. Multivari-able models were used to explore the gain in the predictive accuracy of the models. This predictive accuracy was quantified by the concordance index statistic and was validated with 200 bootstrap resamples. Results: In standard multivariable analyses,TGF-β1 (P

Original languageEnglish
Pages (from-to)3785-3791
Number of pages7
JournalClinical Cancer Research
Volume14
Issue number12
DOIs
Publication statusPublished - Jun 15 2008

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers'. Together they form a unique fingerprint.

  • Cite this

    Shariat, S. F., Karam, J. A., Walz, J., Roehrborn, C. G., Montorsi, F., Margulis, V., Saad, F., Slawin, K. M., & Karakiewicz, P. I. (2008). Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clinical Cancer Research, 14(12), 3785-3791. https://doi.org/10.1158/1078-0432.CCR-07-4969